BiotechTube
Home/Pipeline/SLX-100 (in-licensed from Solaxa)

SLX-100 (in-licensed from Solaxa)

Not Specified

DevelopmentActive

Key Facts

Indication
Not Specified
Phase
Development
Status
Active
Company
Alvogen

About Alvogen

Alvogen is a private, US-based generics and specialty pharma company founded in 2009, headquartered in Parsippany, New Jersey. It operates through distinct business units for generics (Alvogen), brand products (Almatica), injectables (Almaject), and US manufacturing (Norwich). The company's strategy centers on building a targeted portfolio of complex products, leveraging partnerships, and maintaining a lean operational structure to bring affordable medicines to market. A recent major transaction was the 2024 sale of its international business to Lotus, creating a leading international specialized generics platform.

View full company profile

Other Not Specified Drugs

DrugCompanyPhase
FL116Forlong BiotechnologyNot specified
FL117Forlong BiotechnologyNot specified
FL118Forlong BiotechnologyNot specified
FL301Forlong BiotechnologyNot specified
JSKN016AlphaMab OncologyPhase 1
JSKN033AlphaMab OncologyPhase 1
JSKN022AlphaMab OncologyPhase 1
JSKN027AlphaMab OncologyPhase 1
KN019AlphaMab OncologyPhase 1
New TCM FormulationsChina SXT PharmaceuticalsResearch / Pre-clinical
Long-acting LeronlimabCytoDynPreclinical
SR2162SIMR (Australia) BiotechIND Approved